| 000 | 01481 a2200409 4500 | ||
|---|---|---|---|
| 005 | 20250516093031.0 | ||
| 264 | 0 | _c20120917 | |
| 008 | 201209s 0 0 eng d | ||
| 022 | _a2219-2840 | ||
| 024 | 7 |
_a10.3748/wjg.v18.i18.2161 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDrepper, Michael D | |
| 245 | 0 | 0 |
_aClopidogrel and proton pump inhibitors--where do we stand in 2012? _h[electronic resource] |
| 260 |
_bWorld journal of gastroenterology _cMay 2012 |
||
| 300 |
_a2161-71 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAryl Hydrocarbon Hydroxylases _xmetabolism |
| 650 | 0 | 4 |
_aAspirin _xtherapeutic use |
| 650 | 0 | 4 | _aBiotransformation |
| 650 | 0 | 4 |
_aCardiovascular Diseases _xchemically induced |
| 650 | 0 | 4 | _aClopidogrel |
| 650 | 0 | 4 | _aCytochrome P-450 CYP2C19 |
| 650 | 0 | 4 | _aDrug Interactions |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 |
_aGastrointestinal Hemorrhage _xchemically induced |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aPlatelet Aggregation Inhibitors _xadverse effects |
| 650 | 0 | 4 |
_aProton Pump Inhibitors _xadverse effects |
| 650 | 0 | 4 | _aRisk Assessment |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 |
_aTiclopidine _xadverse effects |
| 700 | 1 | _aSpahr, Laurent | |
| 700 | 1 | _aFrossard, Jean Louis | |
| 773 | 0 |
_tWorld journal of gastroenterology _gvol. 18 _gno. 18 _gp. 2161-71 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.3748/wjg.v18.i18.2161 _zAvailable from publisher's website |
| 999 |
_c21796623 _d21796623 |
||